IMMP · Immutep Limited ADR
United States · RS rating 97 · As of 2026-10-14
| Price | 3.38 USD |
|---|---|
| 1-day change | -5.3% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 99 / 99 / 92 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 36 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +30.2% |
| Market cap (USD) | $84.1M |